BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26687439)

  • 1. Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.
    Nijskens CM; Pas SD; Cornelissen J; Caliskan K; Hoek RA; Hesselink DA; van der Eijk AA; de Man RA
    J Clin Virol; 2016 Jan; 74():82-7. PubMed ID: 26687439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period.
    Riezebos-Brilman A; Verschuuren EA; van Son WJ; van Imhoff GW; Brügemann J; Blokzijl H; Niesters HG
    J Clin Virol; 2013 Nov; 58(3):509-14. PubMed ID: 24055152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
    Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
    Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with hepatitis E virus in kidney transplant recipients in southeastern France.
    Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P
    J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.
    Galante A; Pischke S; Polywka S; Luetgehethmann M; Suneetha PV; Gisa A; Hiller J; Dienes HP; Nashan B; Lohse AW; Sterneck M
    Transpl Infect Dis; 2015 Aug; 17(4):617-22. PubMed ID: 26094550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
    Goyal R; Kumar A; Panda SK; Paul SB; Acharya SK
    Antivir Ther; 2012; 17(6):1091-6. PubMed ID: 22910532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
    Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
    J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.
    Pischke S; Suneetha PV; Baechlein C; Barg-Hock H; Heim A; Kamar N; Schlue J; Strassburg CP; Lehner F; Raupach R; Bremer B; Magerstedt P; Cornberg M; Seehusen F; Baumgaertner W; Klempnauer J; Izopet J; Manns MP; Grummer B; Wedemeyer H
    Liver Transpl; 2010 Jan; 16(1):74-82. PubMed ID: 19866448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric liver transplanted patients and prevalence of hepatitis E virus.
    Laverdure N; Scholtès-Brunel C; Rivet C; Heissat S; Restier L; Bacchetta J; Boillot O; Dumortier J; Lachaux A
    J Clin Virol; 2015 Aug; 69():22-6. PubMed ID: 26209371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
    von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
    J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
    Chen S; Wei F; Wu T; Xia N
    Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulation of genotype 4 hepatitis E virus in Europe: first autochthonous hepatitis E infection in France.
    Tessé S; Lioure B; Fornecker L; Wendling MJ; Stoll-Keller F; Bigaillon C; Nicand E
    J Clin Virol; 2012 Jun; 54(2):197-200. PubMed ID: 22405947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus and the kidney in solid-organ transplant patients.
    Kamar N; Weclawiak H; Guilbeau-Frugier C; Legrand-Abravanel F; Cointault O; Ribes D; Esposito L; Cardeau-Desangles I; Guitard J; Sallusto F; Muscari F; Peron JM; Alric L; Izopet J; Rostaing L
    Transplantation; 2012 Mar; 93(6):617-23. PubMed ID: 22298032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First case report of an acute hepatitis E subgenotype 3c infection during pregnancy in Germany.
    Tabatabai J; Wenzel JJ; Soboletzki M; Flux C; Navid MH; Schnitzler P
    J Clin Virol; 2014 Sep; 61(1):170-2. PubMed ID: 24996764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of hepatitis E virus in patients with acute hepatitis in Venezuela.
    García CG; Sánchez D; Villalba MC; Pujol FH; de Los Ángeles Rodríguez Lay L; Pinto B; Chacón EP; Guzmán MG
    J Med Virol; 2012 Jul; 84(7):1025-9. PubMed ID: 22585718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.